Literature DB >> 7243036

[Clinico-functional data concerning chronic asthmatic bronchitis patients treated wih guacetisal].

G Bande, M Coghe, M Meloni, G Nonne.   

Abstract

Guacetisal was administered to a group of patients suffering from chronic asthmatic bronchitis. The drug in question was shown to possess a good fluidifying, expectorant and indirect anti-cough action, by means of an initial increase of the bronchial secretions and a subsequent progressive decrease of secretions towards the end of the treatment. The analysis of the respiratory parameters examined showed no modifications of statistical significance.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7243036

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  2 in total

1.  Bariatric Surgeries and COVID-19 Outcomes: More and More Benefits.

Authors:  Ahmad A Toubasi
Journal:  Obes Surg       Date:  2021-07-07       Impact factor: 4.129

Review 2.  COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection.

Authors:  Stephany Beyerstedt; Expedito Barbosa Casaro; Érika Bevilaqua Rangel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-01-03       Impact factor: 3.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.